IOMM-LeeHomo sapiens (Human)Cancer cell line
Also known as: IntraOsseous Malignant Meningioma-Lee, IOMMLEE, IOMM Lee, Iomm-Lee, IOMM-LEE
AI Summary
No AI-generated summary available for this cell line.
Basic Information
Database ID | CVCL_5779 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Brain[UBERON:UBERON_0000955] |
Donor Information
Age | 61 |
---|---|
Age Category | Adult |
Sex | Male |
Disease Information
Disease | Meningioma |
---|---|
Lineage | CNS/Brain |
Subtype | Meningioma |
OncoTree Code | MNG |
DepMap Information
Source Type | Academic lab |
---|---|
Source ID | ACH-000629_source |
Known Sequence Variations
Type | Gene/Protein | Description | Zygosity | Note | Source |
---|---|---|---|---|---|
MutationSimple | TERT | c.1-124C>T (c.228C>T) (C228T) | Unspecified | In promoter | from parent cell line Hep-G2 |
MutationSimple | BRAF | p.Val600Glu (c.1799T>A) | Unspecified | - | PubMed=26214590 |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Amelogenin
X
CSF1PO
9,10
D13S317
8,9
D16S539
12,13
D5S818
11,13
D7S820
11,12
TH01
6,7
TPOX
8,11
vWA
17,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines
Loading gene expression data...
Publications
Tumor-derived cell culture model for the investigation of meningioma biology.
Anderson M.P., Uhlmann E.N., Kipper F.C., Krichevsky A.M.
J. Neuropathol. Exp. Neurol. 80:1117-1124(2021).
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Sellers W.R.
Nature 569:503-508(2019).
Genomic profile of human meningioma cell lines.";
Dunn I.F.
PLoS ONE 12:E0178322-E0178322(2017).
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.
Golub T.R., Root D.E., Hahn W.C.
Sci. Data 1:140035-140035(2014).
A comparison of the cell lines used in meningioma research.";
Jensen R.L.
Surg. Neurol. 70:295-307(2008).
A genetic strategy to overcome the senescence of primary meningioma cell cultures.
VandenBerg S.R., Feuerstein B.G., Deen D.F., McDermott M.W., Lal A.
J. Neurooncol. 78:113-121(2006).